Cole Mitchell, PA
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations.
Across 54 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Miach Orthopaedics, Inc.$166
- Lilly USA, LLC$138
- AbbVie$126
- Zimmer Biomet$104
- Boehringer Ingelheim$90
- GSK$70
- plus $390 from 14 others
What the payments were for
- Food & beverage$1,085100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Miach Orthopaedics, Inc. | 1 | $166 |
| Lilly USA, LLC | 9 | $138 |
| AbbVie | 6 | $126 |
| Zimmer Biomet | 2 | $104 |
| Boehringer Ingelheim | 4 | $90 |
| GSK | 4 | $70 |
| Novartis | 4 | $64 |
| Dynavax Technologies Corporation | 4 | $56 |
| Johnson & Johnson | 3 | $50 |
| Orthofix Medical, Inc. | 5 | $50 |
| Sanofi-aventis U.S. LLC | 2 | $33 |
| Bayer | 2 | $31 |
| Moximed, Inc | 1 | $18 |
| Solventum Corporation | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Axonics, Inc. | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Lucid Diagnostics Inc. | 1 | $11 |
| Organon | 1 | $7 |
How this compares
$1,085 in reported general payments places this provider in the 70th percentile of 121 surgical providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 109 | $459 |
| Diclofenac Sodium | 21 | $350 |
| Ondansetron Hcl | 49 | $324 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $296 |
| Meloxicam | 59 | $269 |
| Methylprednisolone | 30 | $265 |
| Gabapentin | 12 | $53 |
| Tramadol Hcl | 22 | $33 |
| Prednisone | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other surgical in Sandy
- Leslie MadoreSandy$652
- Scott HadfieldSalt Lake City$10K
- Brittany CrossSalt Lake City$6K
- Jason HoldenDraper$6K
- Stephen LoperAmerican Fork$5K
- Drew LambourneProvo$4K
- Brittney TaylorSalt Lake City$4K
- Richard ClowardOgden$4K
- David TranterDraper$3K
- Bradley BurtonAmerican Fork$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.